Previous 10 | Next 10 |
home / stock / hypmy / hypmy news
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Hypera S.A. ADR (HYPMY) is expected to report for quarter end 2023-09-30
2023-07-05 13:49:50 ET Hypera ( OTCPK:HYPMY ) had declared $0.0445/share quarterly dividend . Payable for shareholders of record July 7; ex-div July 6. See HYPMY Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Hypera goes ex-d...
Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. During a volatile quarter, the portfolio held up better than the Morningstar Global Markets ex-US Index...
A strong M&A strategy alongside massive dividend increases has increased payout ratios well above 100% in the past. The coronavirus pandemic crisis has caused massive pain to sales and EBITDA margins in the worst time possible. A reduction of ~$410 million per year in dividend...
In Reais, I believe there is a 30% upside on Hypera S.A. due to improving margins as the company increases its operation by acquiring other brands and internal development. 75% of the Sell-Side Analysts in Brazil believe that Hypera is a buy and the rest have a neutral rating on the c...
Four out of thirty-seven Brazilian ADRs scored five out of five on the dividend binomial test and they have an equalweight average 2022 forward dividend yield of 7.6%. My preliminary tests show that my Brazilian Dividend Portfolio should produce a dividend yield of over 7%. I beli...
Hypera SA ( OTCPK:HYPMY ) is the largest pharmaceutical company in Brazil. The stock has performed poorly for a good reason: its top brass got caught bribing high level political leaders in Brazil. Since then, the stock has recovered and many have more room to go. Sales have been growing, the ...
Actionable Conclusions (1-10): Analysts Predicted 9.8% To 41.2% Net Gains For Top Ten Healthcare Equities By April 2019 Two of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. ...
Actionable Conclusions (1-10): Analysts Predicted 4.22% To 26.43% Net Gains For Top Ten Healthcare Equities By February 2019 Four of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (...
News, Short Squeeze, Breakout and More Instantly...
Hypera Pharma - ADR Company Name:
HYPMY Stock Symbol:
OTCMKTS Market:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...